GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Balance Sheet Cash And Cash Equivalents

BerGenBio ASA (OSL:BGBIO) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Balance Sheet Cash And Cash Equivalents?

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


BerGenBio ASA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Balance Sheet Cash And Cash Equivalents
Traded in Other Exchanges
Address
Nygardsgaten 114, Bergen, NOR, 5008
BerGenBio ASA is a clinical-stage biopharmaceutical company developing drugs for aggressive diseases, including drug resistant and metastatic cancers and respiratory disease. Its product, bemcentinib (BGB324), is a selective, potent, oral small molecule AXL inhibitor that has been tested in a various indications including NSCLC, AML and severe respiratory infections.